Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Cardiff Oncology Inc. buy BiotechBee

Cardiff Oncology Inc.
Start price
€3.73
20.07.25 / 50%
Target price
€8.00
31.05.27
Performance (%)
-41.07%
End price
€2.20
30.07.25
Summary
This prediction ended on 30.07.25 with a price of €2.20. The BUY prediction by BiotechBee for Cardiff Oncology Inc. performed very badly with a performance of -41.07%. BiotechBee has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Cardiff Oncology Inc. 9.677% 9.677%
iShares Core DAX® 0.734% -0.964%
iShares Nasdaq 100 -2.686% -2.409%
iShares Nikkei 225® -2.261% -4.038%
iShares S&P 500 -1.346% -1.510%

According to BiotechBee what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Trovagene diskutieren
Prediction Buy
Perf. (%) -41.07%
Target price 8.000
Change
Ends at 31.05.27

Buy mit Kursziel 8,0

BiotechBee 
0
Report Share
20.07.25
In the thread Trading Trovagene
Prediction Buy
Perf. (%) -41.07%
Target price 8.000
Change
Ends at 31.05.27

Buy beendet

BiotechBee 
0
Report Share
30.07.25

Stopped prediction by BiotechBee for Cardiff Oncology Inc.

buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.42
11.05.25
€10.00
30.06.27
41.94%
08.06.25

Could be very worthwhile Investment >20% year
BiotechBee 
11.05.25 60%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€4.28
29.04.24
€5.00
31.07.26
-51.11%
08.09.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%